Olvera N

No ORCID on file · 2 papers in corpus · active 2015-2018
2018
Science advances ·doi:10.1126/sciadv.aaq1090

Patients with high-grade serous ovarian carcinoma (HGSC) exhibit poor 5-year survival rates, which may be significantly improved by early-stage detection. The U.S. Food and Drug Administration-approved biomarkers for HGSC-CA-125 (cancer ant…

2015
Neoplasia (New York, N.Y.) ·doi:10.1016/j.neo.2014.12.007

The molecular etiology of uterine leiomyosarcoma (ULMS) is poorly understood, which accounts for the wide disparity in outcomes among women with this disease. We examined and compared the molecular profiles of ULMS and normal myometrium (NL…